Entry |
|
Name |
Tavapadon (USAN/INN) |
Formula |
C19H16F3N3O3
|
Exact mass |
391.1144
|
Mol weight |
391.34
|
Structure |

|
Efficacy |
Antiparkinsonian, Dementia therapeutic agent, Dopamine receptor agonist |
Comment |
Treatment of Parkinson's disease, cognitive impairment, apathy in Alzheimer's disease
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD1
D11431 Tavapadon (USAN/INN)
DRD5
D11431 Tavapadon (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C8x C 7.9100 -13.5800
2 C8x C 7.9100 -14.9800
3 C8y C 9.1224 -15.6800
4 C8y C 10.3349 -14.9800
5 N5x N 10.3349 -13.5800
6 C8x C 9.1224 -12.8800
7 C1d C 9.1224 -17.0798
8 O2a O 11.5660 -15.6910
9 X F 7.7224 -17.0798
10 X F 10.5224 -17.0798
11 X F 9.1224 -18.4798
12 C8y C 12.7712 -14.9953
13 C8x C 13.9535 -15.6781
14 C8y C 15.1660 -14.9783
15 C8y C 15.1662 -13.5783
16 C8x C 13.9838 -12.8955
17 C8x C 12.7713 -13.5953
18 C8y C 16.3956 -12.8684
19 C8y C 17.6013 -13.5645
20 C8y C 18.8137 -12.8645
21 N4x N 18.8138 -11.4645
22 C8y C 17.6082 -10.7684
23 N4y N 16.3957 -11.4684
24 C1a C 17.6015 -14.9796
25 O5x O 20.0451 -13.5754
26 O5x O 17.6085 -9.3804
27 C1a C 15.1767 -10.7644
28 C1a C 16.3970 -15.6893
BOND 30
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 3 7 1
8 4 8 1
9 7 9 1
10 7 10 1
11 7 11 1
12 8 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 15 18 1
20 18 19 2
21 19 20 1
22 20 21 1
23 21 22 1
24 22 23 1
25 18 23 1
26 19 24 1
27 20 25 2
28 22 26 2
29 23 27 1
30 14 28 1
|